We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2875:TSEToyo Suisan Kaisha, Ltd. Analysis

Data as of 2026-03-11 - not real-time

¥11,515.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Toyo Suisan is trading in a bullish market environment with price holding above its intermediate‑term moving average while still under the short‑term average, indicating a potential upside corridor. The momentum indicators are mixed: RSI sits in a neutral zone and the MACD histogram is negative, suggesting short‑term bearish pressure despite the broader bullish trend. Support sits just below the current price, providing a cushion, while resistance aligns with the recent yearly high, framing a modest upside target that analysts see as achievable. Volatility is elevated, yet beta remains low, reflecting limited sensitivity to market swings and a defensive sector profile. The company’s fundamentals are solid – strong cash reserves, modest debt, healthy profitability margins, and a dividend yield that comfortably exceeds the payout threshold, supporting dividend sustainability. Recent nine‑month revenue growth outpaced the prior year, and consensus analyst sentiment remains positive, reinforcing a buy stance with an estimated upside of around eight percent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support level
  • Bearish MACD histogram indicating short‑term pressure
  • Stable dividend yield providing income cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation metrics relative to target price
  • Strong cash position and low leverage
  • Defensive consumer staple sector with steady demand

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by robust cash flow
  • Low beta and defensive industry positioning
  • Consistent profitability and modest debt levels

Key Metrics & Analysis

Financial Health

Revenue Growth-2.00%
Profit Margin12.55%
P/E Ratio18.3
ROE13.03%
ROA8.07%
Debt/Equity0.63
P/B Ratio2.2

Technical Analysis

TrendBullish
RSI43.2
Support¥11,295.00
Resistance¥12,405.00
MA 20¥11,931.00
MA 50¥11,420.20
MA 200¥10,427.89
MACDBearish
VolumeStable
Fear & Greed Index76.41

Valuation

Target Price¥12,463.64
Upside/Downside8.24%
GradeUndervalued
TypeValue
Dividend Yield2.08%

Risk Assessment

Beta0.21
Volatility24.26%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.